TY  - JOUR
AU  - López Gutiérrez, Irene
AU  - García Bueno, Borja
AU  - Caso Fernández, Javier Rubén
AU  - García Bueno, Borja
AU  - Leza Cerro, Juan Carlos
AU  - Muñoz Madrigal, José Luis
PY  - 2019
DO  - 10.1007/s12035-019-01695-6
SN  - 0893-7648
UR  - https://hdl.handle.net/20.500.14352/88880
T2  - Molecular Neurobiology
AB  - The reduction of brain noradrenaline levels is associated to the initiation of Alzheimer’s disease and contributes to its progression. This seems to be due mainly to the anti-neuroinflammatory actions of noradrenaline. The analysis of noradrenaline...
LA  - eng
M2  - 8628
PB  - Springer
KW  - Noradrenaline
KW  - Reboxetine
KW  - CCL2
KW  - MCP-1
KW  - 5xFAD
KW  - Neuroinflammation
TI  - Reboxetine Treatment Reduces Neuroinflammation and Neurodegeneration in the 5xFAD Mouse Model of Alzheimer's Disease: Role of CCL2
TY  - journal article
VL  - 56
ER  -